Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 PhosphataseTingting Sun, Thomas F. Westbrook, Nicola Aceto et al.|Cell|2011Cited by 276
Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II StudyC. Kent Osborne, Mark Sellers, Patrick Neven et al.|Clinical Cancer Research|2011Cited by 181
A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancerLuca Malorni, Ilenia Migliaccio|Oncotarget|2016Cited by 170
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancerCristina Guarducci, Ilenia Migliaccio|npj Breast Cancer|2018Cited by 134
Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes ResistanceLuca Malorni, Rachel Schiff, Carmine De Angelis et al.|Molecular Cancer Research|2016Cited by 49